ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Avacta (AVCT.LSE)
Avacta share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · London Stock Exchange · United Kingdom
£0.615▼ -1.60%
Prices as of Oct 27, 2026 · GBP
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Avacta in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Avacta
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Avacta a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between £0.566 and £0.664; in 9 out of 10, between £0.490 and £0.767. Estimated annual volatility is 38%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- £301M
- Market cap (USD)
- $400M
- 52-week high
- £0.920
- 52-week low
- £0.480
- Revenue (12 months)
- £0.1M
- Net margin
- 0.0%
- Beta
- -0.16
What this means
ATLAS does not publish a fair value for AVCT.LSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks AVCT.LSE has traded between £0.480 and £0.920. Today it is 33.2% below that high and 28% above its low.
Its beta is -0.16: it tends to move less than the market.
About the company
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.
Want to see everything about Avacta?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Avacta do?
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.
What is the chance AVCT.LSE goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, AVCT.LSE ends the month between £0.566 and £0.664.
How big is Avacta and what is its P/E ratio?
Avacta's market capitalization is £301M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is AVCT.LSE?
ATLAS estimates annual volatility at 38%. In a typical month, half of the outcomes end between £0.566 and £0.664.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer